# Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer

> **NCT05656794** · PHASE2 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 40 (estimated)

## Conditions studied

- Prostate Metastases

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT05656794
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-09
- **Primary completion:** 2031-08
- **Final completion:** 2031-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05656794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05656794, "Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05656794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*